Ovarian Cancer
City of Hope, Imugene Begin Trial of Oncolytic Virus in Advanced Solid Cancers
The partners will see if the oncolytic virus CF33-hNIS, dubbed Vaxinia, can increase PD-L1 tumor expression and make patients responsive to Merck's Keytruda.
Singapore-Based Inex Innovate Receives CE Mark for Rapid Ovarian Cancer Test
The point-of-care test can be used in an operating theater to determine whether an ovarian cyst is benign or malignant.
Break Through Cancer Awards $50M in Grants for Collaborative Projects in Ovarian, Pancreatic, Brain Cancers
The grant funding will support projects investigating why drug development efforts have stalled or failed in these three intractable cancers.Â
Preclinical Data In Hand, City of Hope to Study Anti-TAG72 CAR T-Cell Therapy for Ovarian Cancer
At AACR, researchers described plans for an upcoming trial of an autologous CAR T-cell therapy infused directly into the peritoneal cavity of epithelial ovarian cancer patients.
UPenn Researchers Enrolling BRCA1/2 Carriers Into Inovio hTERT Cancer Vaccine study
Research into cancer interception tactics still have a long way to go, but studies like that of Inovio's INO 5401 could offer a framework, a prominent cancer researcher suggested at AACR.